Literature DB >> 2690463

Cardiac abnormalities in liver cirrhosis.

S S Lee.   

Abstract

Cirrhosis is associated with several circulatory abnormalities. A hyperkinetic circulation characterized by increased cardiac output and decreased arterial pressure and peripheral resistance is typical. Despite this hyperkinetic circulation, some patients with alcoholic cirrhosis have subclinical cardiomyopathy with evidence of abnormal ventricular function unmasked by physiologic or pharmacologic stress. Florid congestive alcoholic cardiomyopathy develops in a small percentage, but the concurrent presence of cirrhosis seems to retard the occurrence of overt heart failure. Even nonalcoholic cirrhosis may be associated with latent cardiomyopathy, although overt heart failure is not observed. Tense ascites is associated with some cardiac compromise, and removing or mobilizing ascitic fluid by paracentesis or peritoneovenous shunting results in short-term increases in cardiac output. Cirrhosis also appears to be associated with a decreased risk of major coronary atherosclerosis and an increased risk of bacterial endocarditis. Small hemodynamically insignificant pericardial effusions may be seen in ascitic patients. The release of atrial natriuretic peptide appears to be unimpaired in cirrhosis, although the kidney may be hyporesponsive to its natriuretic effects.

Entities:  

Mesh:

Year:  1989        PMID: 2690463      PMCID: PMC1026787     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  90 in total

1.  The incidence of myocardial infarction in portal cirrhosis.

Authors:  W C GRANT; F WASSERMAN; P L RODENSKY; R V THOMSON
Journal:  Ann Intern Med       Date:  1959-10       Impact factor: 25.391

2.  Circulatory changes in chronic liver disease.

Authors:  J F MURRAY; A M DAWSON; S SHERLOCK
Journal:  Am J Med       Date:  1958-03       Impact factor: 4.965

3.  Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis.

Authors:  G Decaux; P Cauchie; A Soupart; M Kruger; F Delwiche
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

4.  Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain.

Authors:  C J Limas; N H Guiha; O Lekagul; J N Cohn
Journal:  Circulation       Date:  1974-04       Impact factor: 29.690

5.  Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

Authors:  C E Jahn; E J Schaefer; L A Taam; J H Hoofnagle; F T Lindgren; J J Albers; E A Jones; H B Brewer
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

6.  [Cardiac output during liver diseases. Effects of portacaval anastomosis and diuretics].

Authors:  P Even; F Nicollo; J P Benhamou; R Fauvert
Journal:  Rev Int Hepatol       Date:  1966

Review 7.  Intrahepatic circulation in liver disease.

Authors:  P M Huet; G Pomier-Layrargues; J P Villeneuve; F Varin; A Viallet
Journal:  Semin Liver Dis       Date:  1986-11       Impact factor: 6.115

8.  Reticuloendothelial function in patients with alcoholic liver cirrhosis.

Authors:  G Lahnborg; L Friman; L Berghem
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

9.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

10.  The "jaundiced heart": a possible explanation for postoperative shock in obstructive jaundice.

Authors:  J Green; R Beyar; S Sideman; D Mordechovitz; O S Better
Journal:  Surgery       Date:  1986-07       Impact factor: 3.982

View more
  26 in total

1.  Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

Authors:  Kent Feng; Vipul Gupta; Enrique Terrazas; Yerem Yeghiazarians; Thomas Ports; Gabriel Gregoratos; Mehdi Tavakol; John Paul Roberts; Andrew Boyle
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

2.  Alcoholic cirrhosis and cardiomyopathy.

Authors:  T O Cheng
Journal:  West J Med       Date:  1990-02

3.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Combined dynamic contrast-enhanced liver MRI and MRA using interleaved variable density sampling.

Authors:  Mahdi Salmani Rahimi; Frank R Korosec; Kang Wang; James H Holmes; Utaroh Motosugi; Peter Bannas; Scott B Reeder
Journal:  Magn Reson Med       Date:  2014-03-17       Impact factor: 4.668

Review 5.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

6.  Redefining Cirrhotic Cardiomyopathy for the Modern Era.

Authors:  Manhal Izzy; Lisa B VanWagner; Grace Lin; Mario Altieri; James Y Findlay; Jae K Oh; Kymberly D Watt; Samuel S Lee
Journal:  Hepatology       Date:  2019-10-11       Impact factor: 17.425

7.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

8.  Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis.

Authors:  Tomohide Hori; Shintaro Yagi; Taku Iida; Kentaro Taniguchi; Kentaro Yamagiwa; Chiduru Yamamoto; Takashi Hasegawa; Koichiro Yamakado; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Yukinobu Hori; Kan Takeda; Kazuo Maruyama; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.

Authors:  K S Park; Y Li; Y Zhang; A L Gerbes; H Liu; M G Swain; S S Lee
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 10.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.